在高风险的白内障手术中,晚年并不容易出现手术内并发症
Achia Nemet1,2, Liron Anaki2, Itamar Ben Shitrit2
1Department of Ophthalmology, Assuta Ashdod University Medical Center, Ashdod, Israel.
Clinical ophthalmology (Auckland, N.Z.)
|October 13, 2025
概括
高龄并不会增加高风险白内障手术患者的手术后并发症. 这项研究发现结果没有显著差异,这表明仅仅年龄并不是一个禁忌.
科学领域:
- 眼科医生 眼科 眼科
- 老年医学 老年医学
- 外科手术的结果
背景情况:
- 白内障手术在老年人群中很常见.
- 术前风险分层对于管理高风险患者至关重要.
- 晚年对手术后并发症的影响需要进一步研究.
研究的目的:
- 为了确定晚年 (80岁及以上) 是否会增加高风险白内障手术队列中的手术内并发症.
- 分析晚年和手术结果之间的关联,包括手术时间,并发症率和视力敏度.
主要方法:
- 对100名高风险白内障手术患者的回顾性分析.
- 80岁以下的患者与80岁以上的患者的比较.
- 评估的结果包括手术时间,并发症率 (例如,手术内松动虹膜综合征) 和术后最佳校正视力敏度 (BCVA).
- 多变量模型调整为术前风险因素和眼部并发症.
主要成果:
- 没有明显的差异在手术内松动虹膜综合征的发病率或使用手术辅助器之间的年龄组.
- 一周后的术后BCVA在年轻和老年患者之间是可比的.
- 高龄与手术时间或手术挑战没有相关性.
- 经过对并发症进行调整后,随着年龄的增长观察到BCVA恶化的趋势,但这对于所有模型都没有达到统计意义.
结论:
- 高龄 (80岁以上) 并不是高风险白内障手术中手术后并发症的独立风险因素.
- 在精心挑选的高风险患者中,年龄不应被视为白内障手术的禁忌.
- 进一步的研究可能会探讨特定患者亚组中与年龄相关的微妙影响对视力恢复的微妙影响.
更多相关视频
04:59Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
Published on: July 7, 2023
3.0K
04:00Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
1.2K
相关概念视频
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
227
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
227
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
187
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
187
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
196
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
196
01:22Aneurysm IV: Nursing Management
375
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
375
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
234
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
234
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232